Taste Note - Amazon Investing Best Sellers
The Little Book of Valuation: Damodaran's Field Guide to What a Business Is Worth
A Kurums Book Taste review of The Little Book of Valuation for finance leaders who sign off on deals, budgets, and capital requests and want valuation logic they can defend in one page.
Why this book fits Kurums
Every finance team values things constantly - an acquisition target, a new product line, a minority stake, the company itself at the next funding round - and most do it with a spreadsheet inherited from someone else. Damodaran, NYU Stern's 'Dean of Valuation', compresses three decades of teaching into a small book that explains what each number in that spreadsheet is actually claiming.
For the Kurums Finance audience the value is discipline under pressure: a clear line between intrinsic value and relative pricing, a way to stress-test growth assumptions before a board does, and specific playbooks for the hard cases - young companies, cyclicals, distressed firms, banks - where standard templates quietly break.
What the book argues
The foundational argument is that every valuation is a story told in numbers, and both halves must agree. Intrinsic value rests on four drivers: cash flows from existing assets, expected growth in those cash flows, the length of the growth period, and the discount rate that reflects risk. Damodaran insists that each input be traceable to a business narrative - market size, margins, reinvestment - and that a narrative without numbers is a pitch while numbers without a narrative are a spreadsheet exercise. The discipline is to make them check each other.
The second argument separates valuation from pricing. Most real-world deals are priced with multiples - EV/EBITDA, P/E, price-to-sales - borrowed from 'comparable' firms, and Damodaran shows how often this smuggles in the market's mood and mismatched fundamentals. His rule is not to abandon multiples but to understand what drives each one (growth, risk, return on capital), control for those drivers when comparing, and never confuse a fair price relative to peers with a fair value in absolute terms. When the whole sector is mispriced, relative valuation simply inherits the error.
The second half is a tour of the cases where templates fail, each with a specific fix. Young growth companies need revenue-driven stories and explicit failure probabilities rather than terminal values built on fantasy margins. Mature firms hide value in restructuring options. Cyclicals and commodity businesses must be valued on normalized earnings, not this year's peak or trough. Financial companies require equity-based models because debt is raw material, not capital structure. Distressed firms need survival probabilities. The closing message is humility with structure: you will be wrong, so be wrong transparently, update when the story changes, and stop pretending precision you do not have.
Key ideas, translated to your desk
Make the story and the numbers agree
Write the three-sentence business narrative before touching the model. Every growth rate, margin, and reinvestment figure must map to a line of that story, or it comes out.
Price is not value
Multiples tell you what the market pays for similar firms today. Run an intrinsic estimate alongside every comps table, and investigate the gap instead of averaging it away.
Normalize before you value
Cyclical peaks and one-off charges distort everything downstream. Value on mid-cycle earnings and recurring cash flows, then treat the current year as noise around that anchor.
Use it at work
- Require a one-paragraph narrative and a driver table with every acquisition or capex valuation that reaches the investment committee.
- Add an intrinsic cross-check to every multiples-based deal price and document why the two differ.
- Build a normalized-earnings view for cyclical business units before setting their targets or valuing them for sale.
- Assign explicit failure probabilities to early-stage investments instead of hiding risk in an inflated discount rate.
Read it if
- You approve or prepare valuations for M&A, fundraising, impairment tests, or capital allocation.
- You want the logic behind DCF and multiples without a 700-page textbook.
- You liked Common Stocks and Uncommon Profits and want the quantitative partner to Fisher's judgment.
You can skip it if
- You already teach or practise valuation professionally - go straight to Damodaran's full texts.
- You want stock tips; the book teaches a method, not picks.
- You need jurisdiction-specific tax or accounting treatment - this is the economic logic, not the compliance manual.
This book appears in
Curated Tasting Menus that chain this title into a reading route.
Discover more from Kurums | Business Intelligence
Subscribe to get the latest posts sent to your email.